Search research articles
Contact Us
Filters
Showing results (111-120 of 297) with videos related to
Page
of 30
Sort By:
Frontiers in Psychiatry
|
August 16, 2021
Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
Naomichi Okamoto, Tomoya Natsuyama, Ryohei Igata, et al.
The International Journal of Neuropsychopharmacology
|
April 4, 2017
Response to Dr. Okumura
Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Neuropsychiatric Disease and Treatment
|
April 8, 2014
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hikaru Hori, Kenji Yamada, Dan Kamada, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 11, 2007
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran
Koji Shinkai, Yumiko Toyohira, Reiji Yoshimura, et al.
International Clinical Psychopharmacology
|
December 13, 2006
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients
Hikaru Hori, Reiji Yoshimura, Yasuhisa Yamada, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura, Nobuhisa Ueda, Hikaru Hori, et al.
Omega
|
March 27, 2023
Risk Factors in Japanese Drug Overdose Patients: Identifying Their Associations With Suicide Risk
Naomichi Okamoto, Atsuko Ikenouchi, Enkhmurun Chibaatar, et al.
Psychiatria Danubina
|
November 15, 2024
PATIENT WITH PARKINSON'S DISEASE AND DEPRESSIVE SYMPTOMS ASSOCIATED WITH IMPULSE CONTROL DISORDER
Kanae Migita, Naomichi Okamoto, Atsuko Ikenouchi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
Hikaru Hori, Reiji Yoshimura, Nobuhisa Ueda, et al.
Journal of Clinical Psychopharmacology
|
January 16, 2010
Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels
Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, et al.
Page
of 30
Search research articles
Search
Showing results (111-120 of 297) with videos related to
Sort By:
Page
of 30
Frontiers in Psychiatry
|
August 16, 2021
Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
Naomichi Okamoto, Tomoya Natsuyama, Ryohei Igata, et al.
The International Journal of Neuropsychopharmacology
|
April 4, 2017
Response to Dr. Okumura
Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
Neuropsychiatric Disease and Treatment
|
April 8, 2014
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hikaru Hori, Kenji Yamada, Dan Kamada, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 11, 2007
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran
Koji Shinkai, Yumiko Toyohira, Reiji Yoshimura, et al.
International Clinical Psychopharmacology
|
December 13, 2006
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients
Hikaru Hori, Reiji Yoshimura, Yasuhisa Yamada, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura, Nobuhisa Ueda, Hikaru Hori, et al.
Omega
|
March 27, 2023
Risk Factors in Japanese Drug Overdose Patients: Identifying Their Associations With Suicide Risk
Naomichi Okamoto, Atsuko Ikenouchi, Enkhmurun Chibaatar, et al.
Psychiatria Danubina
|
November 15, 2024
PATIENT WITH PARKINSON'S DISEASE AND DEPRESSIVE SYMPTOMS ASSOCIATED WITH IMPULSE CONTROL DISORDER
Kanae Migita, Naomichi Okamoto, Atsuko Ikenouchi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
Hikaru Hori, Reiji Yoshimura, Nobuhisa Ueda, et al.
Journal of Clinical Psychopharmacology
|
January 16, 2010
Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels
Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, et al.
Page
of 30